secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2023-01-05T23:59:59+00:00
Accession:  0001021771-23-000002
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative Therapies reincorporates from Delaware to Nevada as of Dec 31, 2022
--------------------------------------------------------------------------------

- Reincorporation approved by stockholders on Nov 3, 2022; effective Dec 31, 2022 via merger of DE corp into NV subsidiary.
- Each outstanding share of common and Series B preferred converted 1:1 into Nevada corporation shares.
- Outstanding options, warrants, restricted stock, and equity plans assumed by Nevada corporation on identical terms.
- Directors and officers unchanged; no change in business, headquarters, assets, or liabilities.
- Stockholder rights modified under Nevada law vs. Delaware; details in Sept 23, 2022 proxy statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000102177123000002/0001021771-23-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000102177123000002/form8kdtd12292022.htm
  HTML page:      https://secwatch.observer/filing/0001021771-23-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer